Skip to content
Wednesday, November 11, 2026
Discover expert reviews, strategies, and tips for online ca…

Zimbabwe Turns Down ‘One-Sided’ American Healthcare Assistance Deal Due to Data Fears

Health aid image
The proposed US funding was aimed at programmes for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has turned down a substantial American health deal worth 367 million US dollars (£272m) over five years over Washington's insistence on sensitive data.

This rejection became public after a internal memorandum dated December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the deal was "skewed".

A government spokesperson later explained that the US was demanding access to health data for scientific study and commercial gain while refused to share the resulting advantages from any future vaccines.

"We will now turn to the difficult and regrettable task of ending our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the United States had provided more than $1.9bn as health assistance to Zimbabwe during the past twenty years.

A physicians' group in Zimbabwe has urged continued negotiations to find a agreement suitable to both sides so the nation's critical HIV programme can continue.

Wider Background

Zimbabwe's decision follows a comparable situation in neighbouring Kenya, where a court halted a related deal with the US after legal challenges were filed about the security of Kenyans' health data.

Since returning to the presidency recently, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.

USAID had administered assistance for the US government, but Trump argued its spending was "inefficient" and his administration was seeking direct bilateral deals to enhance transparency and accountability.

Based on statements, Sixteen African countries have to date signed these new agreements, constituting over $18.3bn of fresh investment.

Details of the Declined Deal

The funds for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We believe this partnership could have provided immense advantages for Zimbabwean communities, especially the 1.2 million presently on antiretroviral therapy via US-supported programmes," Tremont added.

However, government spokesperson Nick Mangwana said the arrangement was "unequal".

"Our nation was requested to surrender its genetic material and health information for a long time, without any equivalent assurance of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that provided information," his statement read.

"Put simply, our country would supply the basic resources for medical research with no certainty that the end products would be accessible to our population if a new pandemic emerge."

National Interest and International Frameworks

He also pointed out that the US's withdrawal from the global health body and its pursuit of bilateral deals were upending systems previously set up via the global organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to deal with future pandemics.

"This mechanism is designed to ensure that when a country provides its data, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised solely by those with the resources to develop them."

These objections over the US deal "must not be interpreted as hostility towards the US," he added.

"We welcome ongoing discussions with our US partners on how future collaboration might be designed in a manner that honours the sovereignty and interests of each country."

Medical Community Reaction

A leading public health body expressed it understood the official position, but urged that talks need to persist since a large portion of the nation's Aids initiatives relied on foreign aid.

"In cases where technical issues exist, such as those relating to data governance or implementation frameworks, these can often be resolved via detailed discussion and mutually agreed protections," the group said.

The situation highlights the continuing debate between accepting much-needed international aid and safeguarding local interests in an increasingly data-driven world.

Written by

Melissa Graves

A seasoned gaming analyst with over a decade of experience in reviewing online casinos and developing winning strategies for players worldwide.

BoldSlot Platform

Type to search articles.